Robert Klein is President of Klein Financial Corporation, a real estate investment banking consulting company focused on affordable housing finance and development with a record of approximately $3 billion in financing and developing public and private projects. Klein is also Chairman of the California Institute for Regenerative Medicine.
Klein’s commitment to advancing medical research originated in his youngest son Jordan’s diagnosis with juvenile diabetes in 2001. In 2002, Klein was principal negotiator in the passage of a $1.5 billion mandatory federal funding bill for an additional five years of Type 1 and Type 2 diabetes supplemental National Institutes of Health research funding. More recently, Klein was Chairman of the California Proposition 71 committee, the ?California Stem Cell Research and Cures? ballot initiative, passed in November 2004 by 59 percent of the California electorate.